newsfilter
← Latest News
FDA Approved Drugs·

Approval of Riabni, Bla #761140

Approval Date: 09/29/2026; Drug Name: Riabni, Bla #761140; Active Ingredients: RITUXIMAB-ARRX; Company: Amgen Inc; Submission Status: Approval; Application Number: 761140

Company
AMGEN INC
Keywords
AMGEN INC